Prime Editing
Prime editing is a gene-editing technology sometimes described as a search-and-replace system for DNA. It uses a modified CRISPR system plus a reverse transcriptase enzyme and a guide RNA that carries the desired edit. Prime editing may be able to make several kinds of small DNA changes, but it remains technically complex. Delivery, efficiency, off-target effects, and clinical safety are major questions.
Why it matters
Prime editing could one day matter for rare diseases caused by specific DNA changes, but it is still an emerging platform that needs careful evidence before families can know where it fits.
Related content
What Is Gene Therapy?
Gene therapy is a treatment approach that tries to address disease at the level of the gene, often by adding, replacing, silencing, or editing genetic instructions.
Dr. Guoping Feng (MIT) on SHANK3 Gene Therapy, Brain Disorders, and What’s Coming Next
Dr. Guoping Feng
Welcome — I’m Ron Kleiman, and this is GENEration Hope. In this episode, I’m joined by Dr. Guoping Feng, Professor of Neuroscience at MIT, affiliated with the McGovern Institute, the Yang Tan Collective, and the Broad Institute. 
What AI Drug Discovery Could Mean for Rare Disease Families
AI drug discovery is entering a new phase: not just better software, but a new industrial stack linking frontier models, pharma data, robotics, and real experiments.
Why it matters: Rare disease research often starts with small datasets, limited funding, urgent timelines, and difficult trial design. AI-linked discovery systems could help researchers generate stronger candidates and better experiments faster, but families should watch for clinical validation, access, manufacturing, and clear evidence rather than hype.
Source: GENEration Hope editorial analysis